Steven D. Gore, MD¹, Lawrence Morris, MD², Ivana Gojo, MD³, Marcel P. Devetten, MD⁴, Katarzyna Jamieson, MD⁵, Mikkael A. Sekeres, MD, MS⁶, Robert J. Arceci, MD, PhD⁷, Robert L. Redner, MD⁸, Tianna Dauses, BSN^1*, Esther L Schachter-Tokarz^9*, Ibitayo Owoeye, MD^1* and Robert E. Gallagher, MD¹⁰

¹The Sidney Kimmel Comprehensive Cancer Ctr. at Johns Hopkins, Baltimore, MD
²BMT Group of Georgia, Atlanta, GA
³University of Maryland Medical Center, Baltimore, MD
⁴Lied Transplant Center 8718, UNMC, Omaha, NE
⁵University of Florida, Gainesville, FL
⁶Hematologic Oncology and Blood Disorders R35, Cleveland Clinic, Cleveland, OH
⁷Bunting-Blaustein Cancer Research Building, Sidney Kimmel CCC at Johns Hopkins, Baltimore, MD
⁸Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA
⁹Oncology, Albert Einstein School of Medicine, Bronx, NY
¹⁰Montefiore Medical Center, Bronx, NY

Said Dermime^1*, Cynthia Lehe^1*, Hazem Ghebeh^1*, Abdullah Al-Sulaiman^1*, Ghofran Al Qudaihi^1*, Khaled Al-Hussein^1*, Fahad Almohareb^2*, Naeem A. Chaudhri, MD, FACP³, Fahad Z. Alsharif, MBChB, MD⁴, Hazza Al-Zahrani^2*, Said Y Mohamed^2*, Abdelghani Tbakhi^2* and Mahmoud Aljurf, MD³

¹Tumor immunology section, Research center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
²Adult Hematology Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
³King Faisal Specialist, Riyadh, Saudi Arabia
⁴Kfcc, KFSHRC, MBC #64, Riyadh, Saudi Arabia

Xavier Thomas¹, Ida Lobe^2*, Emmanuel Raffoux^2*, Nicolas Boissel^2*, Quoc-Hung Le^1*, Franck Nicolini¹, Adrienne de Labarthe^2*, Sandrine Hayette^3*, Jean-Michel Cayuela^2* and Hervé Dombret²

¹Department of Hematology, Hôpital Edouard Herriot, Lyon, France
²Department of Hematology, Hôpital Saint-Louis, AP-HP, Paris, France
³Hematology, Centre Hospitalier Lyon Sud, Pierre Bénite, France

Robert Kenneth Stuart, MD¹, Gary Acton^2* and AS1411-201 Investigator Group^2*

¹Medical Univ. of S. Caroline, Charleston, SC
²Antisoma Research Ltd, London

Bayard Powell, Ralph D'Agostino Jr., PhD^*, Denise Levitan, MD, Leslie Renee Ellis, MD, Susan Lyerly, PA-C^*, Megan Skiles, PA-C^*, Megan Manuel, NP^*, Robin Harrelson, RN^*, Claire Kimbrough^* and David Duane Hurd, MD

Wake Forest Univ. School of Med., Winston Salem, NC

Gautam Borthakur, MD¹, Stefan Faderl^2*, Srdan Verstovsek^2*, Dan Jones, MD, PhD^3*, Zeev Estrov^2*, Susan O'Brien^2*, Joyce Bass^2* and Hagop Kantarjian²

¹Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX
²M.D. Anderson Cancer Ctr., Houston, TX
³Department of Hematopathology, M.D. Anderson Cancer Ctr., Houston, TX

Jenny E Hernandez, BSc^1*, Joan Zape^2*, Keith Glaser, Ph.D.^3*, Elliot Landaw, M.D., Ph.D.^4*, Cecilia Fu, M.D.⁵ and Kathleen M. Sakamoto, M.D., Ph.D.²

¹David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA
²Pediatrics, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA
³Cancer Research, Abbott Laboratories, Abbott Park, IL
⁴Biomathematics, David Geffen School of Medicine, University of California, Los Angeles, Los, CA
⁵Pediatrics A2-412 MDCC, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, CA

Minoru Yoshida^1*, Kazuo Tamura^2*, Masahiro Imamura, MD³, Yoshiro Niitsu^4*, Takeshi Sasaki^5*, Akio Urabe^6*, Kazuma Ohyashiki^7*, Tomoki Naoe⁸, Akihisa Kanamaru^9*, Mitsune Tanimoto^10* and Tohru Masaoka^11*

¹Dept of IM, Teikyo Univ Sch of Med, Kawasaki, Japan
²Fukuoka Univ., Fukuoka, Japan
³Dept of Hematol, Hokkaido Univ Sch of Med
⁴Dept of IM, Sapporo Medical Univ
⁵Dept of Hematol, Tohoku Univ Sch of Med
⁶Div of Hematol, NTT Kanto Medical Ctr
⁷Dept of IM, Tokyo Medical Univ
⁸Dept of Hematol, Nagoya Univ Sch of Med
⁹Dept of IM, Kinki Univ Sch of Med
¹⁰Dept of Hematol Oncol, Okayama Univ Sch of Med
¹¹Dept of IM, Osaka Med Ctr for Cancer and Cardiovascular Dis Hosp, Japan

Ursula Creutzig, MD¹, Martin Zimmermann^2*, Gertjan Kaspers, MD, PhD³ and Dirk Reinhardt, MD, PhD⁴

¹Universitats-Kindeklinik, Munster, Germany
²Department of Pediatric Hematology-Oncology, Medical School Hanover, Hannover, Germany
³VU University Medical Center, Amsterdam, Netherlands
⁴Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany

Bing Z. Carter, PhD¹, Duncan H. Mak^1*, Wendy D. Schober^1*, Erich Koller, PhD^2*, Clemencia Pinilla, PhD^3*, Lyubomir T. Vassilev, PhD^4*, John C. Reed, MD, PhD⁵ and Michael Andreeff, MD, PhD¹

¹Stem Cell Transplantation & Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
²Isis Pharmaceuticals, Inc., Carlsbad, CA
³Torrey Pines Institute for Molecular Studies, San Diego, CA
⁴Hoffman La-Roche Inc., Nutley, NJ
⁵Burnham Institute for Medical Research, La Jolla, CA

Nelli Bejanyan, MD^1*, Alex Z Fu, PhD^2*, Rao Fu^3*, Matt Kalaycio, MD⁴, Anjali Advani, MD⁵, Ronald Sobecks, MD⁶, Edward A. Copelan⁷ and Mikkael A. Sekeres, MD, MS⁸

¹Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²Quantitative Health Sciences, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³Cleveland Clinic Lerner College of Medicine, Cleveland, OH
⁴Cleveland Clinic Foundation, Cleveland, OH
⁵Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Center
⁶Cleveland Clinic, Cleveland, OH
⁷Hematologic Oncology and Blood Disorders, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
⁸Hematologic Oncology and Blood Disorders R35, Cleveland Clinic, Cleveland, OH

Bing Z. Carter, PhD¹, Duncan H. Mak^1*, Stephen Morris^2*, Gautam Borthakur, MD^3*, Elihu Estey, MD^4*, Anna L. Byrd, RN^3*, Marina Konopleva, MD, PhD³, Hagop M. Kantarjian, MD^3* and Michael Andreeff, MD, PhD¹

¹Stem Cell Transplantation & Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX
²Aegera Therapeutics, Inc., Montreal, QC, Canada
³Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴University of Washington, Seattle, WA

Geoffrey L. Uy, MD, Michael P. Rettig, PhD, Kyle M. McFarland^*, Lindsay M. Hladnik, PharmD^*, Shashikant Kulkarni, PhD^*, Camille N. Abboud, MD, Amanda F. Cashen, MD, Keith Stockerl-Goldstein, MD, Ravi Vij, MBBS, Peter Westervelt, MD, PhD and John F. DiPersio, MD, PhD

Washington University School of Medicine, Saint Louis, MO

Jeffrey E. Lancet, MD¹, Elliott F. Winton, MD², Robert K. Stuart, MD³, Michelle Burton, RN^1*, Christopher Cubitt, PhD^1*, Michelle Blaskovich^1*, John Wright, MD, PhD^4*, Said Sebti, PhD^1* and Daniel Sullivan, MD, MS¹

¹H. Lee Moffitt Cancer Ctr. & Rsrch. Institute, Tampa, FL
²Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
³Medical Univ. of S. Carolina, Charleston, SC
⁴IDB CTEP NCI, Rockville, MD

Jianmin Wang, MD, Shuqing Lü^*, Jianmin Yang^*, Xianmin Song^*, Li Chen^*, Jun Hou^*, Weiping Zhang^*, Chongmei Huan^*, Xiong Ni^* and Huiying Qiu^*

Department of Hematology, Changhai Hospital,, Second Military Medical University, Shanghai, China

Luca Maurillo^*, Alessandra Spagnoli^*, Mariella Genuardi^*, Monia Lunghi^*, Nicola Di Renzo^*, Alfonso Maria D'Arco^*, Giuseppe Mele^*, Alessandro Levis^*, Antonella Gozzini^*, Mario Petrini^*, Manuela Mianulli^*, Grazia Sanpaolo^*, Alberto Santagostino^*, Giuseppe Pietrantuono^*, Fiorella D'Auria^*, Dario Ferrero^*, Gianluca Gaidano^*, Felicetto Ferrara^*, Adriano Venditti^*, Giuseppe Leone^*, Valeria Santini^* and Pellegrino Musto

Italian Cooperative Group on Azacytidine in Myelodysplastic Syndromes and Acute Myeloid Leukemias, Rionero in Vulture and Rome, Italy

Marc E Buyse, ScD^1*, Pierre Squifflet, MSc^2*, Jacob M Rowe, MD³, John K Whisnant, MD^4*, Dileep Bhagwat, PhD, MBA^4*, Stephane E Allard, MD^4*, Kristoffer Hellstrand, MD, PhD^5* and Mats L Brune, MD⁶

¹International Drug Development Institute and Hasselt University, Diepenbeek, Louvain-la-Neuve, Belgium
²International Drug Development Institute, Louvain-la-Neuve, Belgium
³Hematology and BMT, Rambam Medical Center and Technion, Haifa, Israel
⁴EpiCept Corporation, Tarrytown, NY
⁵Infectious Diseases, University of Gothenburg, Gothenburg, Sweden
⁶Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden

Esther Natalie Oliva, MD¹, Roberto Latagliata^2*, Giorgina Specchia³, Francesca Ronco^1*, Giuliana Alimena⁴, Domenico Pastore^3*, Stella Impera^5*, Patrizia Guglielmo^5*, Ida Carmosino^6*, Iolanda Vincelli^1*, Caterina Alati^1*, Massimo Breccia^4*, Laura Napoleone^2* and Francesco Nobile^7*

¹Hematology, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
²Dipartimento di Biotecnologie Cellulari ed Ematologia, Universitŕ "La Sapienza", Rome, Italy
³Chair of Hematology, University of Bari, Italy
⁴Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome,, Rome, Italy
⁵Hematology, Presidio Ospedaliero Garibaldi-Nesima, Catania, Italy
⁶Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza of Rome, Rome, Italy
⁷Hematology Unit, Azienda Ospedaliera " Bianchi-Melacrino-Morelli", Reggio Calabria, Italy

Jerzy Holowiecki¹, Sebastian Grosicki^1*, Slawomira Kyrcz-Krzemien^1*, Kazimierz Kuliczkowski^2*, Marek Kielbinski^2*, Aleksander B. Skotnicki^3*, Beata Piatkowska-Jakubas^3*, Andrzej Hellmann, MD, PhD^4*, Agnieszka Wierzbowska^5*, Marek Seweryn^1*, Beata Stella-Holowiecka^1* and Maria Sadus-Wojciechowska^1*

¹Dept. of Hematology and BMT, Silesian Medical University Hospital SPSKM, Katowice, Poland
²Dep.of Hematology, Wroclaw Medical University, Wroclaw, Poland
³Collegium Medicum, Jagiellonian University, Cracow, Poland
⁴Department of Hematology, Medical University of Gdansk, Gdansk, Poland
⁵Medical University,Lodz,Poland, Lodz, Poland

Michael Maris, MD^1*, Larry D. Cripe, MD², Robert K Stuart, MD³, Farhad Ravandi, MBBS⁴, Glenn C Michelson, MD^5*, Rachel E. Hawtin, PhD^5*, Lyra E Ericson^5* and Craig J. Berman, MD^5*

¹Bone Marrow Transplantation, Rocky Mountain Cancer Center, Denver, CO
²Indiana University Simon Cancer Center, Indianapolis, IN
³Medical Univ. of S. Caroline, Charleston, SC
⁴Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
⁵Clinical Science, Sunesis Pharmaceuticals, South San Francisco, CA

Jacob M. Rowe, MD¹, Xiaopan Yao, Ph.D^2*, Peter A. Cassileth, MD³, Frederick R. Appelbaum, MD⁴, Peter H. Wiernik, MD⁵, Charles Schiffer, MD⁶, Mark R. Litzow, MD⁷, Selina Luger, MD⁸, John M. Bennett, MD⁹, Hillard M Lazarus, MD^10* and Martin S Tallman¹¹

¹Hematology and Bone Marrow Transplantation, Rambam Health Care Campus and Technion, Israel Institute of Technology, Haifa, Israel., Haifa, Israel
²Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA
³Univ. of Miami Sylvester Cancer Ctr., Miami, FL
⁴Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA
⁵New York Medical College, Our Lady of Mercy Cancer Center, Bronx, NY
⁶Wayne State University, Detroit
⁷Mayo Clinic, Rochester, MN
⁸Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁹University of Rochester, Rochester, NY
¹⁰Ireland Cancer Center, University Hospitals of Cleveland, Cleveland, OH
¹¹Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL

Richard Schlenk¹, Kristina Sohlbach^2*, Marie-Luise Hütter^3*, Patrice Ceballos^4*, Nathalie Fegueux, MD^5*, Emmanuel Raffoux^6*, Herve Dombret, MD⁷, Mike Dennis^8*, Jo Tomlins^8*, Jette Tjřrnelund^9* and Andreas Neubauer^2*

¹Internal Medicine III, University of Ulm, Ulm, Germany
²Dept. Hematology, Oncology, Immunology, Philipps University Marburg, Marburg, Germany
³University of Ulm, Ulm, Germany
⁴CHU Montpellier and INSERM U475, Montpellier, France
⁵Haematology-Oncology, CHU Montpellier, Montpellier Cedex 5, France
⁶Dept. of Hematology, Hopital Saint Louis, Paris, France
⁷Hopital Saint Louis, Paris, France
⁸Department of Haematology, Christie Hospital NHS Trust, Manchester, United Kingdom
⁹Drug Metabolism and Pharmacokinetics, Topotarget, Copenhagen, Denmark

Caroline J Duncan, MBBS, MRCP(Ed)^1*, Peter R. E. Johnson, MD² and Huw Roddie, MBChB, PhD^3*

¹Centre for Regenerative Medicine, Adult Cell Therapy Group, Edinburgh, United Kingdom
²Haematology, Western General Hospital, Edinburgh, ARRAY(0xc41f4f0)
³Department of Haematology, Western General Hospital, Edinburgh, United Kingdom

Jeffrey Lancet, MD¹, Judith E. Karp, MD², Larry D. Cripe, MD³, Gail J. Roboz, MD⁴, Matt Suster^5*, Nguyen Tan^5*, Rachael Hawtin^5*, Judith Fox^5*, Craig Berman^5* and Glenn Michelson^5*

¹H. Lee Moffitt Cancer Ctr. & Rsrch. Institute, Tampa, FL
²Johns Hopkins University, The Sidney Kimmel Cancer Center at, Baltimore, MD
³Indiana University Simon Cancer Center, Indianapolis, IN
⁴Cornell University, New York, NY
⁵Sunesis Pharmaceuticals Inc, South San Francisco, CA

Ruikun Zhong, MD^1*, Thomas A. Lane, MD² and Edward D Ball, MD³

¹Moores UCSD Cancer Center, University of California, San Diego, La Jolla, CA
²Moores UCSD Cancer Center, La Jolla, CA
³Medicine, Division of Blood and Marrow Transplantation, UCSD, La Jolla, CA